Meridian Bioscience Inc. | Balance Sheet
Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
44,282.00
43,047.00
49,973.00
47,226.00
57,072.00
59,763
Total Accounts Receivable
26,183.00
23,232.00
26,254.00
27,102.00
29,106.00
32,336
Inventories
34,835.00
35,495.00
35,817.00
45,057.00
41,493.00
41,993
Other Current Assets
8,788.00
10,974.00
10,809.00
7,406.00
6,204.00
4,961
Total Current Assets
114,088.00
112,748.00
122,853.00
126,791.00
133,875.00
139,053
Net Property, Plant & Equipment
26,091.00
27,610.00
27,492.00
30,450.00
30,510.00
29,995
Total Investments and Advances
1,000.00
1,000.00
1,000.00
1,000.00
1,815.00
2,722
Intangible Assets
31,172.00
31,006.00
28,280.00
91,837.00
81,630.00
77,750
Other Assets
3,574.00
3,082.00
2,134.00
1,745.00
1,789.00
1,727
Total Assets
176,748.00
176,929.00
183,282.00
252,028.00
249,777.00
251,377
ST Debt & Current Portion LT Debt
-
-
-
3,750.00
4,500.00
Accounts Payable
5,592.00
4,966.00
6,646.00
7,627.00
7,719.00
Income Tax Payable
979.00
859.00
886.00
1,482.00
1,248.00
Other Current Liabilities
15,132.00
7,910.00
7,719.00
9,712.00
9,420.00
Total Current Liabilities
21,703.00
13,735.00
15,251.00
22,571.00
22,887.00
Long-Term Debt
-
-
-
54,610.00
50,147.00
Provision for Risks & Charges
-
2,078.00
2,067.00
2,193.00
2,332.00
Deferred Taxes
823.00
1,483.00
1,523.00
2,753.00
4,297.00
Other Liabilities
-
87.00
91.00
3,224.00
371.00
Total Liabilities
21,703.00
15,900.00
17,409.00
85,556.00
80,192.00
Common Equity (Total)
155,045.00
161,029.00
165,873.00
166,472.00
169,585.00
Total Shareholders' Equity
155,045.00
161,029.00
165,873.00
166,472.00
169,585.00
Total Equity
155,045.00
161,029.00
165,873.00
166,472.00
169,585.00
Liabilities & Shareholders' Equity
176,748.00
176,929.00
183,282.00
252,028.00
249,777.00
About Meridian Bioscience
View Profile
